Pseudoachalasia is a condition in which symptoms, radiologic, endoscopic, and manometric findings mimick idiopathic achalasia. About 4% of patients with a typical constellation for idiopathic achalasia will turn out to have pseudoachalasia, posing a major diagnostic challenge. A large spectrum of underlying causes of pseudoachalasia has been described. However, in about 70% of affected patients, this condition is caused by a malignancy (mostly adenocarcinoma of the esophagogastric junction or cardia). We describe a 16-year-old high school student referred for management of achalasia who turned out to have pseudoachalasia due to adenocarcinoma of the cardia. He was cured with preoperative chemotherapy followed by radical surgery. Therapy of pseudoachalasia secondary to neoplasia is directed against the tumor or may be palliative to keep the lumen open. Other causes of pseudoachalasia include esophageal motility disturbances as a paraneoplastic phenomenon (e.g., with small cell lung cancer), post fundoplication or post bariatric surgery, in association with a thoracic aortic aneurysm, or with sarcoidosis or amyloidosis. Therapy is directed accordingly to eliminate or correct the underlying cause.
Introduction
Idiopathic achalasia (Greek: failure to relax) is a rare primary motility disorder of the esophagus caused by the loss of nitric oxide and vasoactive intestinal polypeptide releasing inhibitory interneurons in the myenteric plexus that are involved in facilitating lower esophageal sphincter (LES) relaxation for gastric accommodation of food boluses [1] [2] [3] . This results in aperistalsis in the tubular esophagus and impaired relaxation of the LES [4] . The pathogenesis of achalasia is not yet fully understood. Basically, loss of the inhibitory innervation of the esophagus can be due to extrinsic (including central nervous lesions involving the dorsal motor nucleus or the vagal fibers) or intrinsic causes (loss of the inhibitory ganglion cells in the myenteric plexus). At different stages of achalasia, a spectrum of histopathological changes, that is, esophageal myenteric inflammation with subsequent progressive destruction of the myenteric ganglion cells and occurrence of neural fibrosis can be found [5] . It is suggested that this inflammation-associated pathophysiology is due to an autoimmune-mediated response to an unknown insult (probably an indolent viral infection) in genetically susceptible individuals [6, 7] . This is emphasized by the finding of an inflammatory infiltrate in the myenteric plexus in patients with achalasia [3, 8] and a higher prevalence of circulating antimyenteric autoantibodies in those achalasia patients with class II HLA antigens [5, 9] . Degeneration of inhibitory postganglionic neurons of the esophagus and LES due to inflammation [10, 11] may finally lead to impaired relaxation of the LES and hypercontractility of the distal esophagus [12] . However, associated class II HLA antigens are not found in all patients with achalasia, and some data suggest that circulatory antineuronal antibodies could also be the consequence and not the cause of the disease [5] .
Typical clinical symptoms of achalasia include dysphagia for solids and liquids in up to 100% [13] [14] [15] , regurgitation of undigested food (59-64%), chest pain (17-95%, predominantly observed in younger patients [16] ), weight loss (30-91%), and nocturnal cough (11-46%) [13] . Furthermore, patients frequently report problems with belching due to alterations of the upper esophageal belch reflex [17] and hiccups, which are probably the result of esophageal distention and stimulation of afferent vagal fibers [18] . Dyspepsia and the sensation of heartburn often lead to a misdiagnosis of gastroesophageal reflux disease [19] . Thus, it is important to consider the diagnosis of achalasia in patients who do not improve on proton pump inhibitor therapy after initial diagnosis of gastroesophageal reflux disease. Although heartburn is mainly a symptom of gastroesophageal reflux, it occurs in up to 72% of patients with achalasia, even after onset of dysphagia [20] . This sensation might be due to retention of acidic or noxious food contents or to bacterial lactate production in the esophagus [21] .
Pulmonary complications such as structural or functional abnormalities caused by recurrent aspiration or tracheal compression from a dilated esophagus are the most common extraesophageal manifestations of achalasia [22] . Extreme dilatation and distortion of the cervical esophagus ("bull frog neck") may further lead to tracheal obstruction and thus stridor [14] . Whether a selective defect of vagal ganglionic neurons might also affect parts of the gastrointestinal tract other than the esophagus is still unclear; associated delayed gastric emptying or gallbladder dysfunction has been described [6] .
For the diagnosis of achalasia, assessment of esophageal motor function is essential; barium esophagogram and endoscopy are mandatory in addition to manometry. By definition the manometric finding of aperistalsis and incomplete LES relaxation without evidence of mechanical obstruction solidify the diagnosis of achalasia [23] . An increased basal LES pressure, an elevated baseline esophageal body pressure, and simultaneous nonpropagating contractions may also support the diagnosis [24] .
Achalasia does not appear to have a specific gender or ethnic predilection. The incidence is 1 in 100,000 individuals per year with a peak between 30 and 60 years of age; the prevalence is about 10 per 100,000 population [25] [26] [27] .
Case Report
A 16-year-old male high school student, a native of Austria from the state of Carinthia, presented with a 3-month history of dysphagia. He complained that swallowed solids became stuck behind his breast bone and filled up his throat. According to him, he had lost 3 kg of body weight, according to his mother 8 kg. His weight on presentation was 50 kg with a height of 180 cm (BMI 15.5 kg/m 2 , normal 18-24). Physical examination was otherwise unremarkable. He was referred to the University Medical Center of Graz and brought with him images of a barium swallow thought to show features of achalasia ( Fig. 1) . Esophageal manometry revealed a common channel of the body of the esophagus with loss of primary peristalsis. LES pressure was 22 mm Hg with failure to relax completely and to decrease to fundic pressure on swallowing. Endoscopy ( Fig. 2 ) revealed smooth mucosa in the distal esophagus with a closed cardia, which the endoscope could pass when some pressure was applied. A small erosion above the cardia was biopsied. Such erosions in achalasia may be due to food retention. Botulinum toxin was injected along the circumference of the esophagogastric junction, but did not improve his dysphagia thereafter. Endosonography (Fig. 3) showed what was first thought to be a thickened muscularis propria in the area of the LES in this very young man. However, the presence of an enlarged lymph node changed the interpretation and a tumor of about 4.5 cm in diameter was described involving all layers of the esophageal wall. The tumor was behind the left atrium and inseparable from the aorta. Computed tomography (CT) confirmed that the tumor was attached to the aorta, partially encasing it. Biopsy from the erosion showed adenocarcinoma (Fig. 4) . Upon laparoscopy, a tumor encasing part of the cardia was deemed to be inoperable. There was no evidence of distant metastases. Preoperative chemotherapy (methotrexate, fluorouracil, cisplatin, doxorubicin, etoposide, and paclitaxel) [28] shrank the tumor that radical surgery could be performed 4 months later. This entailed total gastrectomy, splenectomy, lymphadenectomy, resection of the major omentum, partial pancreatectomy, and esophagectomy with esophagojejunostomy (retrosternal pull-up). Figure 5 shows the histology of the resected tumor representing well-differentiated tubular adenocarcinoma. Subsequently, the patient did well, accommodated completely to his new anatomy, and has remained free of symptoms. He gets vitamin B 12 once a month intramuscularly, and his body weight is now 59 kg. Three times a year he is given parenteral iron replacement. He will soon get a degree in physical metallurgy and has been free of tumor for a follow-up of 18 years. We have reported on this patient before and briefly after surgery [28, 29] but here we can add a very favorable 18-year follow-up.
Discussion
Pseudoachalasia is a condition in which clinical and manometric features of idiopathic achalasia are mimicked by another abnormality. A large spectrum of underlying causes has been reported, including thoracic aortic aneurysm [30] , rheumatoid arthritis [31] , previous Nissen fundoplication [32] , bariatric surgery and adjustable gastric band placement [33, 34] , amyloidosis [35, 36] , sarcoidosis [37] , systemic mastocytosis [38] , intestinal pseudoobstruction [39] , and Chagas disease [40] . In Fabry disease, the accumulation of lysosomal Gb₃ (globotriaosylceramide) leads to neuronal and vascular dysfunction that may also cause pseudoachalasia [41] . Rarely a peptic stricture can result in a reversible achalasia-like motor pattern [42] . However, in about 70% of affected patients, pseudoachalasia is caused by a primary or secondary malignancy [43, 44] with primary malignancy accounting for 54-70% [44] [45] [46] and secondary malignancy for 6% of cases [47] . Pseudoachalasia as a manifestation of a malignancy was first described by Howarth in 1919 [48] and later by Ogilvie [49] . Carcinoma of the esophagus or cardia with typical strictures of the esophagogastric junction is the tumor most likely to cause pseudoachalasia [50] . Submucosal invasion with secondary destruction of the myenteric plexus is less common [46, 51] . Invasion may have played a role in a case of urothelial carcinoma spreading to the peritoneum and pillars of the diaphragm [52] and expansion to the esophagus has also been reported in a case of cholangiocarcinoma [53] . Besides this association, pseudoachalasia has also been reported as a manifestation of such malignancies as pancreatic cancer [31, 51] , pleural mesothelioma [54] , lung cancer [55] , multiple myeloma [35] , and metastatic breast and cervical carcinoma [56, 57] . Paraneoplastic pseudoachalasia [58] is rare, but recently its incidence has been increasing [51] . In general, the incidence of pseudoachalasia is about 2-4% among patients with manometric findings suggesting achalasia [45, 59, 60] .
Early identification of malignancy-associated pseudoachalasia is important to avoid inappropriate treatment and delay of adequate therapy. Discriminating between idiopathic achalasia and pseudoachalasia is, however, challenging because clinical and diagnostic features, such as radiographic studies, endoscopy, and manometry, are often compatible with both diseases, as was the case in our young patient.
Since esophagogastric junction outflow obstruction is common to both achalasia and pseudoachalasia, high-resolution manometry and bolus transit measurement by impedance have not clearly advanced our ability to differentiate the 2 conditions [27, 61, 62] . In addition to the classical criteria, achalasia might present with a broad spectrum of manometric findings in individual patients. The presence of peristalsis with some swallows, however, hints to pseudoachalasia [31] . Risk factors that suggest malignancy-associated pseudoachalasia include advanced age, short duration of symptoms, considerable weight loss, and difficulty in passing the esophagogastric junction during endoscopy. If 2 or more of these risk factors are present, further investigations are warranted to avoid missing a diagnosis of malignancy-associated pseudoachalasia [50] . The distal esophagus, the cardia, and the surrounding structures must be visualized with endosonography, CT or MRI.
Endoscopy is primarily needed to rule out a mechanical malignancy-associated obstruction. It is a reliable tool to diagnose tumors or strictures of the esophagus or cardia if the tumor crosses the submucosal layer [50] . Patients with achalasia have a normal endoscopy in 44% [13] , and only 4-5% of patients with negative endoscopy and manometry positive for achalasia are diagnosed with pseudoachalasia after the performance of additional investigations [43, 44] . Although the LES pressure is elevated in achalasia, the esophagogasric junction can usually be passed meeting no more than mild resistance. A firm resistance, nodularity, ulcers, or bleeding with the passage of the endoscope raise concern for neoplastic infiltration or another cause of pseudoachalasia [6, 62] . Esophageal biopsies are recommended in patients with dysphagia to rule out eosinophilic esophagitis. However, it should be noted that an increased number of eosinophils secondary to inflammatory processes due to stasis is frequently found in patients with achalasia [63, 64] . Some patients with achalasia further develop candidiasis secondary to esophageal stasis. Thus, candidiasis in immunocompetent patients may also suggest an esophageal motility disorder [12] .
Endosonography is recommended to differentiate between idiopathic and malignancy-associated achalasia [65] . This method can not only rule out an infiltrating tumor but may also provide supportive evidence for achalasia such as a thickened circular muscle layer [65, 66] . However, it should be noted that a negative test does not always rule out pseudoachalasia [6] . Thus, in patients with negative endosonography but suspected malignancy-associated pseudoachalasia, CT or other cross-sectional imaging is mandatory. Asymmetric esophageal wall thickening, a mass around the esophagogastric junction, or mediastinal lymphadenopathy are characteristic findings associated with pseudoachalasia. Further, CT may reveal metastases or local tumors causing pseudoachalasia [67] . However, in some studies, CT detects malignancy in only 42% of patients with malignancy-associated pseudoachalasia [50] .
Inhalation of amyl nitrate has also been suggested to be useful for differentiating between achalasia and pseudoachalasia, as it relaxes the LES in achalasia but not in pseudoachalasia [45, 68] . Furthermore, technically wellperformed pneumatic dilatation or botulinum toxin injection in the area of the LES provides temporary relief of dysphagia in true achalasia but usually not in pseudoachalasia [69, 70] . Our patient's dysphagia failed to improve following injection of botulinum toxin. In some cases with paraneoplastic pseudoachalasia, a panel of serum markers including antineuronal nuclear antibodies type 1 and antineuronal calcium channel antibodies of P/Q-type and N-type have found to be helpful [58, 71] .
Therapy is directed against the tumor and in the best case is curative, as in the presented case. If the tumor cannot be completely removed or cured (surgery, chemotherapy, radiation), palliative measures such as stenting or even palliative resection are options. Pseudoachalasia not due to a tumor may be difficult to treat, but therapy will also be directed against the underlying cause.
Conclusion
Pseudoachalasia may be the first manifestation of a malignancy and should be suspected in patients with advanced age, short duration of symptoms, considerable weight loss, difficulty in passing the esophagogastric junction during endoscopy, and when technically wellperformed pneumatic dilatation or botulinum toxin injection in the area of the LES does not provide temporary relief of dysphagia. Discriminating between idiopathic achalasia and pseudoachalasia is challenging because clinical and diagnostic features are often compatible with both diseases. However, early identification of malignancy-associated pseudoachalasia is important to avoid inappropriate treatment and delay of adequate therapy.
